0
Article |

SONORAN DERMATOLOGICAL SOCIETY

William E. Carson, MD
Arch Dermatol. 1972;106(4):589-590. doi:10.1001/archderm.1972.01620130099026
Text Size: A A A
Published online

Papular Angioplasia. Presented by the US Naval Hospital, San Diego, Calif.  A 22-year-old white man first noted violaceous papules on his chin three months prior to admission to the hospital. Although the patient has had mild acne vulgaris since age 14, the new lesions were quite distinct in size and color. Soon after the initial lesions appeared, many others erupted on the chin and nose, enlarged rapidly, then became quiescent. They were asymptomatic except for the adverse cosmetic appearance which caused him to seek attention. There was no family history of similar lesions.Many deeply violaceous papulonodular lesions occupied the chin and nasal regions (Figure). They varied from 3 mm to 1 cm in size and were non-tender. In addition, there were a few densely indurated plaque-like lesions with similar distribution and color. Minimal lesions of acne vulgaris were on the face, neck, and trunk.Laboratory findings disclosed concomitant infectious

REFERENCES

Wood JH:  Vascular tumors of the skin , in Helwig EB (ed.): The Skin Baltimore , Williams & Wilkins Co, 1971;.
Caro WA:  Benign lymphoid hyperplasia and malignant lymphomas of the skin , in Helwig EB (ed.): The Skin Baltimore , Williams & Wilkins Co, 1971;, p 573.
Wilson-Jones E, Marks R:  Papular angioplasia , Arch Dermatol 102:422-427, 1970;.
Sweeley CC, Klionsky B:  Fabry's disease: Classification as sphingolipidosis and partial characterization of novel glycolipid . J Biol Chem 238:3148-3150, 1963;.
von Gemmingen G, Kierland RR, Opitz JM:  Angiokeratoma corporis diffusum (Fabry's disease) . Arch Dermatol 91:206-218, 1965;.
Perrelet A, Forssman WG, Franceschetti AT, et al:  A study of Fabry's disease . Dermatologica 138:222-227, 1969;.
Brady RO, Gal AE, Bradley RM, et al:  Enzymatic defect in Fabry's disease . New Eng J Med 21:1163-1167, 1967;.
Kint JA:  Fabry's disease: Alpha galactosidase deficiency . Science 167:1268-1269, 1970;.
Handa S, Ariga T, Miyatake T, et al:  Presence of α-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease . J Biochem 69:625-627, 1971;.
Mapes CA, Anderson RL, Sweeley CC:  Enzyme replacement in Fabry's disease: An inborn error of metabolism . Science 169:987-989, 1970;.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Wood JH:  Vascular tumors of the skin , in Helwig EB (ed.): The Skin Baltimore , Williams & Wilkins Co, 1971;.
Caro WA:  Benign lymphoid hyperplasia and malignant lymphomas of the skin , in Helwig EB (ed.): The Skin Baltimore , Williams & Wilkins Co, 1971;, p 573.
Wilson-Jones E, Marks R:  Papular angioplasia , Arch Dermatol 102:422-427, 1970;.
Sweeley CC, Klionsky B:  Fabry's disease: Classification as sphingolipidosis and partial characterization of novel glycolipid . J Biol Chem 238:3148-3150, 1963;.
von Gemmingen G, Kierland RR, Opitz JM:  Angiokeratoma corporis diffusum (Fabry's disease) . Arch Dermatol 91:206-218, 1965;.
Perrelet A, Forssman WG, Franceschetti AT, et al:  A study of Fabry's disease . Dermatologica 138:222-227, 1969;.
Brady RO, Gal AE, Bradley RM, et al:  Enzymatic defect in Fabry's disease . New Eng J Med 21:1163-1167, 1967;.
Kint JA:  Fabry's disease: Alpha galactosidase deficiency . Science 167:1268-1269, 1970;.
Handa S, Ariga T, Miyatake T, et al:  Presence of α-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease . J Biochem 69:625-627, 1971;.
Mapes CA, Anderson RL, Sweeley CC:  Enzyme replacement in Fabry's disease: An inborn error of metabolism . Science 169:987-989, 1970;.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.